TYRP1 and melanoma: Specifically, treatment with PMMEXOs in B16-F10 melanoma cells led to decreased expression of MITF, TYR, TRP-1 and TRP-2, suggesting that PMMEXOs suppress melanin synthesis through the suppression of MITF-mediated transcriptional activation of melanin biosynthetic enzymes (Figure 4).